Team:Edinburgh/Modelling/Genomic

From 2010.igem.org

Revision as of 11:22, 19 August 2010 by JRWK (Talk | contribs)







Overview: Modelling genomic BRIDGEs


Unlike the modelling of genetic regulation networks or metabolic pathways, modelling a generic protocol does not achieve much in light of the ultimate goal of being able to understand and answer questions regarding biological processes. On the other hand, we did wish to have a model corresponding to the BRIDGE protocol, and such a model would be useful to demonstrate an ability of Kappa that has not been touched upon yet: perturbations. These are described in further detail below, but in short allow for certain effects (such as activation or inhibition of rules) to be enacted at certain times within simulation of the model.

The sections below describe, in turn: the agents and rules that are present in the model, the perturbations that govern time-dependent behaviour, the results of running the simulation, and analysis of the results obtained.



The Model


The genomic BRIDGE model, focused as it is on interactions the BRIDGE protocol, requires only one basic agent - the DNA agent presented previously in the introduction to Kappa. Each DNA agent has two lateral sites to bind other DNA agents both upstream and downstream, one to hold the type of the agent (usually materialised either as a descriptive acronym or as a reference number from the BioBrick Registry), and one to bind proteins interacting with the DNA agent (typically transcription factors or RNA polymerase, omitted in this model ). This basic agent, chained together as shown in Figure 1, can then be used to construct larger composite agents that represent different sequences in the BRIDGE protocol - for example, the cat-sacB construct or the insert.




Figure 1: A composite agent with four DNA agents joined together at their upstream and downstream sites, representing the cat-sacB construct and surrounding DNA.



The rules involved in the BRIDGE protocol can be roughly divided into three distinct groups. The first group involves the introduction of fresh agents to the protocol, and consists of a single rule in which the desired insert (i.e., the DNA that we wish to insert into the target vector during the second stage of BRIDGE recombination) is created. This rule has an unmodified rate of 0, since we do not want this to occur without our express permission.

The second group of rules involves the degradation of various composite agents under the influence of antibiotics or growth on sucrose, as per the selection methods employed by the BRIDGE protocol. For example, applying antibiotic selection will result in all composite agents not containing a DNA agent with type cat to degrade; similarly, applying growth on sucrose will cause all composite agents containing a DNA agent with type sacB to degrade. Again, this will only occur at certain time-points within the model, and thus the rate of the rules are set at zero.

The third and final group of rules describe the two stages of recombination as outlined in Figure 1 on the introduction to the BRIDGE protocol here. They involve the exchange of the relevant DNA agents between their respective composites, an example of which is shown in Figure 2 below.

The initial conditions of the simulation are set such that it contains both the cat-sacB construct and the vector into which the final insert needs to be placed. The remaining DNA required for the protocol - the insert itself - will be added to the simulation at a predetermined point in time, as described by the perturbations to follow.








Figure 2: A Kappa rule describing the first stage of recombination in the BRIDGE protocol. The cat-sacB construct is exchanged between the two composite agents.





Perturbations


***



Results


***





Analysis


***